{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:22:46Z","timestamp":1787847766330,"version":"build-2784847793"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Hematopoietic stem cell transplantation (HSCT) is used to treat various hematologic diseases, including autologous and allogeneic transplants. As the indications for HSCT have expanded and its clinical application has become more widespread, it is essential to ensure standardized and appropriate use of techniques. A comprehensive assessment of HSCT is an important step in clinical decision-making. To standardize diagnosis and treatment in HSCT clinical practice, an expert panel from the Chinese Collaborative Group on the Transformation of Infectious Immunology and Microecology Research participated in this evaluation to provide guidance for the management of HSCT in clinical practice.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_2416_25","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:00:10Z","timestamp":1779951610000},"page":"248-259","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Chinese guidelines on comprehensive assessment of clinical practice in hematopoietic stem cell transplantation\u0394"],"prefix":"10.4103","volume":"22","author":[{"given":"Xiaoxuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hong Kong University Shenzhen Hospital, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan Asia General Hospital, Wuhan University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shenzhen Hospital, Southern Medical University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu J.","family":"Cao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Chemical Oncogenomics, Shenzhen Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sun Yat-sen University Cancer Center, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sun Yat-sen University Cancer Center, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Southern Medical University, Zhujiang Hospital, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"He","sequence":"additional","affiliation":[{"name":"Department of Hematology, Southern Medical University, Zhujiang Hospital, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjun","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sun Yat-sen University Cancer Center, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Huizhou Central People Hospital, Huizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Suo","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieying","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ren","sequence":"additional","affiliation":[{"name":"School of Medicine, Southern University of Science and Technology, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danian","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqian","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huizhou Central People Hospital, Huizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingye","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Clinical Research Center for Infectious Disease, Shenzhen Third People\u2019s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Deng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"He","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaogui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"China Collaborative Group on Research and Transformation of Infection Immunity and Microecology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260528","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.23.02175","article-title":"Clinical and genomic-based decision support system to define the optimal timing of allogeneic hematopoietic stem-cell transplantation in patients with myelodysplastic syndromes","volume":"42","author":"Tentori","year":"2024","journal-title":"J Clin Oncol"},{"key":"R2-20260528","doi-asserted-by":"crossref","first-page":"2040620720906002","DOI":"10.1177\/2040620720906002","article-title":"Allogeneic hematopoietic stem-cell transplantation for myelofibrosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"R3-20260528","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s12185-016-2106-z","article-title":"Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia","volume":"104","author":"Guo","year":"2016","journal-title":"Int J Hematol"},{"key":"R4-20260528","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hon.3014","article-title":"Outcomes of allogeneic hematopoietic stem cell transplantation for primary hemophagocytic lymphohistiocytosis in adults","volume":"40","author":"He","year":"2022","journal-title":"Hematol Oncol"},{"key":"R5-20260528","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.3324\/haematol.2019.227199","article-title":"Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma","volume":"105","author":"Mika","year":"2020","journal-title":"Haematologica"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3324\/haematol.2021.278933","article-title":"Allogeneic hematopoietic stem cell transplantation from non-sibling 10\/10 HLA-matched related donors: A single-center experience","volume":"106","author":"Shen","year":"2021","journal-title":"Haematologica"},{"key":"R7-20260528","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jtct.2023.08.031","article-title":"Outcomes of autologous stem cell transplantation in patients with ultra-high-risk multiple myeloma","volume":"29","author":"Pasvolsky","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"R8-20260528","doi-asserted-by":"crossref","first-page":"881346","DOI":"10.3389\/fonc.2022.881346","article-title":"First-line autologous stem cell transplantation for mantle cell lymphoma: A systematic analysis and treatment recommendation","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1200\/JCO.20.01751","article-title":"Autologous stem cell transplantation in the management of relapsed non-Hodgkin lymphoma","volume":"39","author":"Alencar","year":"2021","journal-title":"J Clin Oncol"},{"key":"R10-20260528","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/jcrt.jcrt_2102_24","article-title":"Upfront autologous hematopoietic stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma: A real-world multicenter study","volume":"21","author":"Guo","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R11-20260528","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.transproceed.2025.02.042","article-title":"Efficacy and safety of oropharyngeal probiotic BP-OM1 on respiratory infection-like symptoms among patients with lymphoma after autologous hematopoietic stem cell transplantation: A multicenter randomized controlled pilot study","volume":"57","author":"Xiang","year":"2025","journal-title":"Transplant Proc"},{"key":"R12-20260528","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41408-025-01233-9","article-title":"Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: A secondary analysis of an RCT","volume":"15","author":"Xue","year":"2025","journal-title":"Blood Cancer J"},{"key":"R13-20260528","first-page":"2000","article-title":"The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group","volume":"109","author":"Xu","year":"2024","journal-title":"Haematologica"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"1102966","DOI":"10.3389\/fimmu.2023.1102966","article-title":"How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00277-023-05226-1","article-title":"Allogeneic hematopoietic stem cell transplantation remains a feasible approach for elderly with acute myeloid leukemia: A 10-year experience","volume":"102","author":"Duda","year":"2023","journal-title":"Ann Hematol"},{"key":"R16-20260528","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41375-020-1004-9","article-title":"Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: Myth and reality","volume":"35","author":"Del","year":"2021","journal-title":"Leukemia"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3324\/haematol.2022.281020","article-title":"Autologous stem cell transplantation in an older adult population","volume":"107","author":"Fedorov","year":"2022","journal-title":"Haematologica"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.humimm.2022.03.002","article-title":"A clinician's guide to HLA matching in allogeneic hematopoietic stem cell transplant","volume":"83","author":"Mangum","year":"2022","journal-title":"Hum Immunol"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.humimm.2022.04.012","article-title":"Evolution of HLA testing for hematopoietic stem cell transplantation: Importance of the candidate's antibody profile for donor selection","volume":"83","author":"Bettinotti","year":"2022","journal-title":"Hum Immunol"},{"key":"R20-20260528","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11684-017-0595-7","article-title":"Everyone has a donor: Contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation","volume":"13","author":"Lv","year":"2019","journal-title":"Front Med"},{"key":"R21-20260528","first-page":"42","article-title":"Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation","volume":"6","author":"Teshima","year":"2023","journal-title":"Blood Cell Ther"},{"key":"R22-20260528","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N Engl J Med"},{"key":"R23-20260528","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/CM9.0000000000002235","article-title":"Current status and prospects of hematopoietic stem cell transplantation in China","volume":"135","author":"Wang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"R24-20260528","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","article-title":"The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R25-20260528","first-page":"654","article-title":"Comparison of matched sibling, unrelated and haploidentical donors in hematopoietic stem cell transplantation. A real-world experience from the Argentine Group for Bone Marrow Transplantation and Cell Therapy (GATMO-TC)","volume":"80","author":"Trucco","year":"2020","journal-title":"Medicina (B Aires)"},{"key":"R26-20260528","doi-asserted-by":"crossref","first-page":"103576","DOI":"10.1016\/j.transci.2022.103576","article-title":"A study of blood group conversion in patients with ABO incompatible hematopoietic stem cell transplantation \u2013A decade survey","volume":"62","author":"Li","year":"2023","journal-title":"Transfus Apher Sci"},{"key":"R27-20260528","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/cells13110993","article-title":"Prospects and potential for chimerism analysis after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Miura","year":"2024","journal-title":"Cells"},{"key":"R28-20260528","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41409-019-0695-x","article-title":"Full donor chimerism without graft-versus-host disease: The key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)","volume":"55","author":"Feliu","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R29-20260528","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4103\/jcrt.jcrt_32_24","article-title":"Chinese guidelines for integrated diagnosis and treatment of intestinal microecology technologies in tumor application (2024 Edition)","volume":"20","author":"Wang","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R30-20260528","doi-asserted-by":"crossref","first-page":"e15186","DOI":"10.1111\/ctr.15186","article-title":"Tumor and Microecology Committee of China Anti-Cancer Association. Expert consensus on the relevance of intestinal microecology and hematopoietic stem cell transplantation","volume":"38","author":"Wang","year":"2024","journal-title":"Clin Transplant"},{"key":"R31-20260528","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/jpm11020100","article-title":"Fecal microbiota transplantation in allogeneic hematopoietic stem cell transplantation recipients: A systematic review","volume":"11","author":"Pession","year":"2021","journal-title":"J Pers Med"},{"key":"R32-20260528","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/CIRCULATIONAHA.117.032072","article-title":"Letter by Clerkin et al Regarding Article, \u201cImportance of routine antihuman\/leukocyte antibody monitoring: De novo donor specific antibodies are associated with rejection and allograft vasculopathy after heart transplantation\u201d","volume":"137","author":"Clerkin","year":"2018","journal-title":"Circulation"},{"key":"R33-20260528","doi-asserted-by":"crossref","first-page":"7903471","DOI":"10.1155\/2017\/7903471","article-title":"Not all antibodies are created equal: Factors that influence antibody mediated rejection","volume":"2017","author":"Butler","year":"2017","journal-title":"J Immunol Res"},{"key":"R34-20260528","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bbmt.2015.05.001","article-title":"Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation","volume":"21","author":"Ciurea","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R35-20260528","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jtct.2024.09.005","article-title":"ASTCT consensus recommendations on testing and treatment of patients with donor-specific anti-HLA antibodies","volume":"30","author":"Kongtim","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"R36-20260528","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41409-023-01932-6","article-title":"Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation \u2013A systematic review and meta-analysis","volume":"58","author":"Huang","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"R37-20260528","doi-asserted-by":"crossref","first-page":"774.e1","DOI":"10.1016\/j.jtct.2024.05.016","article-title":"Optimizing autologous stem cell transplantation in multiple myeloma: The impact of intensive chemomobilization","volume":"30","author":"Portuguese","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"R38-20260528","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/trf.17829","article-title":"Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center retrospective analysis","volume":"64","author":"Dill","year":"2024","journal-title":"Transfusion"},{"key":"R39-20260528","doi-asserted-by":"crossref","first-page":"770.e1","DOI":"10.1016\/j.jtct.2021.06.016","article-title":"The efficacy and safety of chemotherapy-based stem cell mobilization in multiple myeloma patients who are poor responders to induction: The mayo clinic experience","volume":"27","author":"Vaxman","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"R40-20260528","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: Guidelines from the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R41-20260528","article-title":"Development of novel low-DMSO cryoprotectant for peripheral blood stem cell preservation","author":"Guo","year":"2025","journal-title":"J Vis Exp"},{"key":"R42-20260528","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood.V99.3.731","article-title":"Comparison of 200 mg\/m(2) melphalan and 8 Gy total body irradiation plus 140 mg\/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: Final analysis of the Intergroupe Francophone du My\u00e9lome 9502 randomized trial","volume":"99","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"R43-20260528","doi-asserted-by":"crossref","first-page":"1014306","DOI":"10.3389\/fphar.2023.1014306","article-title":"Safety and efficacy of a modified busulfan\/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia","volume":"14","author":"Shi","year":"2023","journal-title":"Front Pharmacol"},{"key":"R44-20260528","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/16078454.2020.1868783","article-title":"Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"26","author":"Lyu","year":"2021","journal-title":"Hematology"},{"key":"R45-20260528","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MOH.0000000000000833","article-title":"Viral infection after hematopoietic stem cell transplantation","volume":"31","author":"Ljungman","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"R46-20260528","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.2019000956","article-title":"How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation","volume":"135","author":"Einsele","year":"2020","journal-title":"Blood"},{"key":"R47-20260528","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/jcm11051364","article-title":"Thrombocytopenia and therapeutic strategies after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bento","year":"2022","journal-title":"J Clin Med"},{"key":"R48-20260528","doi-asserted-by":"crossref","first-page":"538.e1","DOI":"10.1016\/j.jtct.2024.01.082","article-title":"Cytomegalovirus reactivations in allogeneic hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplantation cyclophosphamide","volume":"30","author":"Chor\u00e3o","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"R49-20260528","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/brain\/awae340","article-title":"CNS manifestations in acute and chronic graft-versus-host disease","volume":"148","author":"Lambert","year":"2025","journal-title":"Brain"},{"key":"R50-20260528","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.3324\/haematol.2023.284649","article-title":"Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes","volume":"109","author":"Galaverna","year":"2024","journal-title":"Haematologica"},{"key":"R51-20260528","doi-asserted-by":"crossref","first-page":"378281","DOI":"10.1155\/2014\/378281","article-title":"Oral complications in hematopoietic stem cell recipients: The role of inflammation","volume":"2014","author":"Haverman","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R52-20260528","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bjh.13344","article-title":"Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant","volume":"169","author":"Labrador","year":"2015","journal-title":"Br J Haematol"},{"key":"R53-20260528","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"R54-20260528","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R55-20260528","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","article-title":"Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: A multicenter prospective observational study","volume":"21","author":"Sun","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R56-20260528","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12885-022-09539-8","article-title":"Oral cryotherapy for management of chemotherapy-induced oral mucositis in haematopoietic cell transplantation: A systematic review","volume":"22","author":"Alsulami","year":"2022","journal-title":"BMC Cancer"},{"key":"R57-20260528","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jmv.24621","article-title":"Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay","volume":"89","author":"Inazawa","year":"2017","journal-title":"J Med Virol"},{"key":"R58-20260528","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbmt.2020.03.013","article-title":"Latent Tuberculosis in hematopoietic stem cell transplantation: Diagnostic and therapeutic strategies to prevent disease activation in an endemic population","volume":"26","author":"Bourlon","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R59-20260528","first-page":"804","article-title":"Oral Mucositis in patients undergoing hematopoietic stem cell transplantation","volume":"33","author":"Ali","year":"2023","journal-title":"J Coll Physicians Surg Pak"},{"key":"R60-20260528","doi-asserted-by":"crossref","first-page":"e13821","DOI":"10.1111\/petr.13821","article-title":"Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers","volume":"24","author":"Falcon","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R61-20260528","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000520824","article-title":"Late-onset, noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation: A nationwide cohort study of long-term survivors","volume":"101","author":"Myrdal","year":"2022","journal-title":"Respiration"},{"key":"R62-20260528","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4103\/jcrt.jcrt_1444_22","article-title":"Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022)","volume":"18","author":"Wang","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R63-20260528","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2012.069559","article-title":"Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients","volume":"98","author":"Labrador","year":"2013","journal-title":"Haematologica"},{"key":"R64-20260528","doi-asserted-by":"crossref","first-page":"1509612","DOI":"10.3389\/fped.2025.1509612","article-title":"Microbiota modulation for infectious complications following allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies","volume":"13","author":"Dai","year":"2025","journal-title":"Front Pediatr"},{"key":"R65-20260528","doi-asserted-by":"crossref","first-page":"00185","DOI":"10.1183\/23120541.00185-2022","article-title":"Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: Current management and future directions","volume":"8","author":"Glanville","year":"2022","journal-title":"ERJ Open Res"},{"key":"R66-20260528","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4103\/jcrt.JCRT_782_23","article-title":"Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2","volume":"19","author":"Wang","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R67-20260528","doi-asserted-by":"crossref","first-page":"e2024065","DOI":"10.4084\/MJHID.2024.065","article-title":"Update on cytomegalovirus infection management in allogeneic hematopoietic stem cell transplant recipients. A consensus document of the spanish group for hematopoietic transplantation and cell therapy (GETH-TC)","volume":"16","author":"Pi\u00f1ana","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R68-20260528","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"R69-20260528","first-page":"389","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I","volume":"21","author":"Jagasia","year":"2015","journal-title":"The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant"},{"key":"R70-20260528","doi-asserted-by":"crossref","first-page":"1544025","DOI":"10.3389\/fmed.2025.1544025","article-title":"Chinese expert consensus on the application of intravenous immunoglobulin in hematological diseases","volume":"12","author":"Guo","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R71-20260528","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S2352-3026(23)00305-8","article-title":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: Updated recommendations by the EBMT\/ELN International Working Group","volume":"11","author":"Kr\u00f6ger","year":"2024","journal-title":"Lancet Haematol"},{"key":"R72-20260528","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.4103\/jcrt.jcrt_33_24","article-title":"The role of fecal microbiota transplantation in the treatment of acute graft-versus-host disease","volume":"20","author":"Guo","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R73-20260528","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO-25-01238","article-title":"Sirolimus and cyclosporine with post-transplant cyclophosphamide or mycophenolate mofetil as graft-versus-host disease prophylaxis in unrelated donor hematopoietic cell transplantation","volume":"43","author":"Oshima","year":"2025","journal-title":"J Clin Oncol"},{"key":"R74-20260528","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: Updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2416_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:36:48Z","timestamp":1787845008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2416_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2416_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}